APC/C (Cdh1) controls the proteasome-mediated degradation of E2F3 during cell cycle exit
Related Experiment Video
Updated: May 22, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Zhen Ping1, Ratna Lim, Tarig Bashir
1Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, The Netherlands.
Abstract:
E2F transcription factors regulate gene expression in concert with the retinoblastoma tumor suppressor family. These transcriptional complexes are master regulators of cell cycle progression and, in addition, control the expression of genes involved in DNA repair, G 2/M checkpoint and differentiation. E2F3 has recently attracted particular attention, because it is amplified in various human tumors. Here we show that E2F3 becomes unstable as cells exit the cell cycle. E2F3 degradation is mediated by the anaphase-promoting complex/cyclosome and its activator Cdh1 (APC/C (Cdh1) ). E2F3 interacts with Cdh1 but not Cdc20, the other APC/C activator. Enforced expression of Cdh1 results in proteasome-dependent degradation of E2F3, whereas the overexpression of Cdc20 has no effect on E2F3 turnover. Finally, silencing of Cdh1 by RNA interference stabilizes E2F3 in differentiating neuroblastoma cells. These findings indicate that the APC/C (Cdh1) ubiquitin ligase targets E2F3 for proteasome-dependent degradation during cell cycle exit and neuronal differentiation.
Insights
E2F3 protein is degraded by the APC/C (Cdh1) complex during cell cycle exit. This regulation is crucial for cell differentiation and preventing tumor formation.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Biology
Background:
- E2F transcription factors are key regulators of cell cycle progression and differentiation.
- E2F3 amplification in human tumors highlights its oncogenic potential.
- Understanding E2F3 regulation is crucial for cancer research.
Purpose of the Study:
- To investigate the regulatory mechanisms controlling E2F3 stability.
- To determine the role of the anaphase-promoting complex/cyclosome (APC/C) in E2F3 degradation.
- To elucidate the specific APC/C activator involved in E2F3 turnover.
Main Methods:
- Co-immunoprecipitation to study protein interactions.
- Western blotting to assess protein levels and degradation.
- RNA interference to silence Cdh1 expression.
- Overexpression studies of APC/C activators (Cdh1 and Cdc20).
Main Results:
- E2F3 protein levels decrease upon cell cycle exit.
- E2F3 degradation is mediated by the anaphase-promoting complex/cyclosome (APC/C) and its activator Cdh1.
- E2F3 interacts with Cdh1 but not Cdc20.
- Cdh1 overexpression leads to E2F3 degradation, while Cdc20 overexpression does not.
- Silencing Cdh1 stabilizes E2F3 in differentiating neuroblastoma cells.
Conclusions:
- The APC/C (Cdh1) ubiquitin ligase targets E2F3 for proteasome-dependent degradation.
- This degradation process is essential for cell cycle exit and neuronal differentiation.
- Targeting the APC/C (Cdh1)-E2F3 pathway may offer therapeutic strategies for tumors with E2F3 amplification.
Related Concept Videos
Anaphase Promoting Complex
Anaphase Promoting Complex
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Negative Regulator Molecules

